Takeda loses again to Hikma in gout drug patent battle by Emily Wasserman Tuesday, May 24, 2016 Takeda suffered a defeat in its battle to keep a competitor to its version of an ancient gout drug off the market after a federal court said that Hikma can sell a med with the same active ingredient as Takeda’s Colcrys.
